Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

Baricitinib may not always prevent relapse in alopecia areata.

A young man was diagnosed with a rare hair loss condition usually seen in older women.

Dermoscopy helps diagnose rare GLPLS in males.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.

Applying a specific inhibitor lightens skin and hair color.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

GI197111X is best dissolved in Capmul MCM for trials.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Ruxolitinib cream may help treat severe hair loss in children.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Abrocitinib may effectively treat stubborn alopecia universalis.

The gene Prss53 affects hair shape and bone development in rabbits.

Baicalin may help reduce excessive male hormone levels in PCOS.

Erlotinib can cause nonscarring hair loss and itchy skin.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.